Profile cover photo
Profile photo
Steven Lott
Steven's posts

Post has shared content
I'm honoured to have been selected to attend the upcoming Gates Foundation's ‪#‎GatesSocial‬ event - looking forward to it!
Ward Health is honoured to have our communications director, +Steven Lott, selected to attend the +gates foundation’s #GatesSocial event on science and innovation.  This is an exciting opportunity to meet with other global health leaders, and recognition of our leading edge work in engaging health care stakeholders in support of the goal of improving health equity and outcomes through better access to care.

Gates Social on science innovation with Nick Kristof (October 6-7, 2014)

Gates Socials are small, in-person events hosted by the Bill & Melinda Gates Foundation. At this event attendees will:
- Participate in a special question-and-answer session with New York Times columnist and author Nick Kristof about how to take action on global health issues and his latest book with wife Sheryl WuDunn, A Path Appears.
- Speak with Gates Foundation CEO Susan Desmond-Hellmann
- Attend a presentation with remarks from Bill & Melinda Gates
- Hear from Gates Foundation employees who work to find great ideas that could save lives and change the world
- See first-hand some of the newest global health innovations currently under development
- Discuss and brainstorm ways social media can help spread the good news about vaccine effectiveness

Ward Health believes that improving health care is a shared responsibility, and we advocate for engaging patients in all aspects of healthcare decision-making and for public policies that foster medical discovery and innovation - the path to improving the quality of life for millions of people.  Innovation also enhances the financial sustainability of health systems by easing the economic and social burden of chronic illness and disease.

Post has shared content
Guest column by +Chris Ward : Is Indian Pharma’s spectacular growth Bonanza or Bubble?

Indian pharmaceutical companies’ profits have grown hugely in recent years. Contrary to claims that India’s robust generics industry is driven by being ‘the drug store for the developing world’, overwhelmingly the growth of the industry is from sales to established country markets in the US and Europe. But predictions for continued growth may prove to be optimistic.

Post has shared content
Will India’s regulatory failures doom the future growth of its pharmaceutical industry? +Chris Ward of +World Health Advocacy  reports.

Feature article from May's edition of Pharmaceutical Executive Global Digest.

Post has attachment
Rick Mercer's rant on those who won't get the flu shot...

Post has attachment

Post has shared content
"If this tablet is approved in coming years, this achievement will surely usher in a new age for science in Africa. It will save millions upon millions of lives on the continent, helping avoid at least 24 percent of child deaths in sub-Saharan Africa."

Post has shared content
An increasing number of adults in the US have multiple chronic conditions.  Growth in the prevalence of multiple chronic conditions was driven primarily by increases in three of the nine individual conditions.  During this 10-year period, prevalence of hypertension increased from 35% to 41%, diabetes from 10% to 15%, and cancer from 9% to 11%, among those 45 and over.

Post has shared content
Times of India story on compulsory licensing gets it wrong

A misleading July 27 Times of India story on U.S. “Compulsory Licensing” of cancer drugs gets it all wrong.  The author misrepresents the importation of generic cancer drugs to deal with a critical shortage as a “Compulsory License”.  The publicly available U.S. FDA’s documentation on the events and actions taken by the agency to address critical cancer drug shortages makes it clear that “FDA’s exercise of enforcement discretion does not mean that the overseas drug is now FDA approved in the US”. (see attached link)

The FDA public documentation makes clear that the temporary importation of drugs “is considered only in cases when there is a shortage of an approved US drug that is critical to patients and the shortage cannot be resolved by manufacturers of the approved US drug in the immediate future. In these cases, FDA searches for companies that manufacture drugs that are approved in foreign markets and may help meet critical patient needs in the US.”

The FDA’s efforts to address a critical drug shortage involves a high level of collaboration among all stakeholders including industry and government.  The assertion by the author that “In case of the US, even the patent right-holder will wake up one morning and discover that the patent had been revoked” is both incorrect and misrepresents a valid, urgent and temporary response to the critical needs of cancer patients.  A temporary importation permit is not a compulsory license.

Post has shared content
The World Health Organization today released their World Health Statistics report, providing information from 194 countries on a broad range of health indicators. Some of the key highlights included:
* In every region of the world, obesity doubled between 1980 and 2008
* In 20 years, the number of maternal deaths has decreased from more than 540 000 deaths in 1990 to less than 290 000 in 2010 – a decline of 47%
* Public health advancements have helped save children’s lives in the past decade

Post has attachment
A great comic re #obesity & #NCDs by Dan Piraro (@pirarobizarro)
Wait while more posts are being loaded